These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 2644876

  • 1. Controlled comparison of ketanserin and nifedipine in Raynaud's phenomenon.
    Codella O, Caramaschi P, Olivieri O, Perbellini L, Perbellini A, Bambara LM, Corrocher R, De Sandre G.
    Angiology; 1989 Feb; 40(2):114-21. PubMed ID: 2644876
    [Abstract] [Full Text] [Related]

  • 2. Ketanserin versus nifedipine in secondary Raynaud's phenomenon.
    Kirch W, Linder HR, Hutt HJ, Ohnhaus EE, Mahler F.
    Vasa; 1987 Feb; 16(1):77-80. PubMed ID: 3554811
    [No Abstract] [Full Text] [Related]

  • 3. Efficacy of ketanserin in the therapy of Raynaud's phenomenon: thermometric data.
    Arosio E, Montesi G, Zannoni M, Perbellini L, Paluani F, Lechi A.
    Angiology; 1991 May; 42(5):408-13. PubMed ID: 2035893
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Therapeutic efficacy of ketanserin, a selective antagonist of the serotonin (5-HT2) receptors, in primary and secondary Raynaud's phenomenon.
    Meloni F, Transi MG, Sciacca V, De Felice C, Bagarone A, Sciacca A.
    Angiology; 1987 Jul; 38(7):530-6. PubMed ID: 3619126
    [Abstract] [Full Text] [Related]

  • 7. Effect of ketanserin on Raynaud's phenomenon in progressive systemic sclerosis: a double-blind trial.
    Lukác J, Rovenský J, Tauchmannová H, Zitnan D.
    Drugs Exp Clin Res; 1985 Jul; 11(9):659-63. PubMed ID: 3916837
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Does serotonin receptor blockade have a therapeutic effect in Raynaud's phenomenon?
    Brouwer RM, Wenting GJ, Visser W, Schalekamp MA.
    Vasa Suppl; 1987 Jul; 18():64-7. PubMed ID: 3299817
    [No Abstract] [Full Text] [Related]

  • 10. Controlled trial of nifedipine in the treatment of Raynaud's phenomenon.
    Smith CD, McKendry RJ.
    Lancet; 1982 Dec 11; 2(8311):1299-301. PubMed ID: 6128596
    [Abstract] [Full Text] [Related]

  • 11. Controlled double-blind trial of the clinical effect of nifedipine in the treatment of idiopathic Raynaud's phenomenon.
    Gjørup T, Kelbaek H, Hartling OJ, Nielsen SL.
    Am Heart J; 1986 Apr 11; 111(4):742-5. PubMed ID: 3513504
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Treatment of Raynaud's syndrome with calcium entry blockers].
    Shcherbakov AB, Guseva NG, Mach ES.
    Ter Arkh; 1987 Apr 11; 59(4):89-92. PubMed ID: 3296288
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Action of nifedipine on the post-ischemic cold hyperemia reaction in Raynaud's phenomenon].
    Vayssairat M, Blaison N, Baudot N, Evenou P, Gilard M, Mathieu JF.
    J Mal Vasc; 1989 Apr 11; 14(4):299-302. PubMed ID: 2584886
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Nifedipine in Raynaud's phenomenon: relationship between immediate, short term and longterm effects.
    Kallenberg CG, Wouda AA, Kuitert JJ, Tijssen J, Wesseling H.
    J Rheumatol; 1987 Apr 11; 14(2):284-90. PubMed ID: 3598997
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.